For sure there's a number of possibilities, it would depend on the economics of whichever deal they went with. For me though the TAMs of the undisclosed indications would have to be lucrative enough to give up a large chunk of the 5 X opportunity that the trio of PMS PMD and AS presents.
Certainly its not a given that Neuren won't market and sell drugs, they have to remain nimble in the face of lowball offers or worse, but the comments made then and in previous communications by Jon and Co makes it increasingly unlikely Neuren will be around for much longer as a standalone entity imo.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.50 |
Change
-0.040(0.32%) |
Mkt cap ! $1.548B | |||
| Open | High | Low | Value | Volume |
| $12.61 | $12.68 | $12.32 | $4.676M | 374.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 175 | $12.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.50 | 3190 | 9 |
View Market Depth
| Last trade - 14.46pm 25/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |